Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 2Phase 4 1Phase 3 1

Status

Terminated 3Completed 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Glioblastoma 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Chloroquine × Clear all
NCT02378532 2020-01-23

CHLOROBRAIN

Maastricht Radiation Oncology

Phase 1 Completed
13 enrolled
CNS

Glioblastoma

NCT02071537 2019-11-25

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

University of Cincinnati

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

NCT01777477 2015-09-22

Adjuvant Effect of Chloroquine on Gemcitabine

University of Zurich

Phase 1 Completed
9 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡